会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • INDAZOLYL DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATING AGENTS
    • 有用的盐酸衍生物作为钾通道调节剂
    • WO2008040753A1
    • 2008-04-10
    • PCT/EP2007/060493
    • 2007-10-03
    • NEUROSEARCH A/SERIKSEN, Birgitte, L.SØRENSEN, Ulrik, SvaneHOUGAARD, CharlotteTEUBER, LenePETERS, DanCHRISTOPHERSEN, PalleJOHANSEN, Tina, Holm
    • ERIKSEN, Birgitte, L.SØRENSEN, Ulrik, SvaneHOUGAARD, CharlotteTEUBER, LenePETERS, DanCHRISTOPHERSEN, PalleJOHANSEN, Tina, Holm
    • C07D403/04A61K31/4439C07D401/04A61K31/506A61P9/00
    • C07D403/04C07D401/04
    • This invention relates to novel indazolyl derivatives of formula (Ia) and (Ib) useful as potassium channel modulating agents, and their use in the preparation of pharmaceutical compositions. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium- channels, in particular respiratory diseases, epilepsy, convulsions, seizures, absence seizures, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, erectile dysfunction, gastrointestinal dysfunction, secretory diarrhoea, ischaemia, cerebral ischaemia, ischaemic heart, disease, angina pectoris, coronary heart disease, autism, ataxia, traumatic brain injury, Parkinson's disease, bipolar disorder, psychosis, schizophrenia, anxiety, depression, mania, mood disorders, dementia, memory and attention deficits, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), dysmenorrhea,narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, arrhythmia, hypertension, myotonic muscle' dystrophia, spasticity, xerostomi, diabetes type II, hypehnsulinemia, premature labour, baldness, cancer, irritable bowel syndrome, immune suppression, migraine and pain.
    • 本发明涉及用作钾通道调节剂的式(Ia)和(Ib)的新的吲唑基衍生物及其在制备药物组合物中的用途。 此外,本发明涉及可用于治疗或缓解与钾通道活动相关的疾病或病症的药物组合物,特别是呼吸系统疾病,癫痫,抽搐,癫痫发作,不发作,痉挛,血管痉挛,冠状动脉痉挛,肾脏疾病 ,多囊性肾病,膀胱痉挛,尿失禁,膀胱流出阻塞,勃起功能障碍,胃肠功能障碍,分泌性腹泻,局部缺血,脑缺血,缺血性心脏病,心绞痛,冠心病,孤独症,共济失调,创伤性脑损伤,帕金森氏病 阿尔茨海默氏病,肌萎缩性侧索硬化症(ALS),痛经,发作性睡眠,雷诺病,间歇性跛行,Sjorgren综合征,心律失常,心律失常,心律失常,精神病,精神分裂症,焦虑症,抑郁症,躁狂症, 高血压,肌强直性肌营养不良,痉挛状态, 口干燥,II型糖尿病,早产,秃顶,癌症,肠易激综合征,免疫抑制,偏头痛和疼痛。